Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints Pfizer's Rita Balice-Gordon to lead neurobiology research

She will be based at the firm's Framingham, Massachusetts R&D site

Sanofi Rita Balice-GordonSanofi has appointed Rita Balice-Gordon as head of its neurobiology research therapeutic area.

She joins the French pharma firm from Pfizer, where she served as head of circuits, neurotransmitters and signaling in the its neuroscience and pain research unit.

During her time there she led a global team and was responsible for the company's worldwide research and development postdoctoral programme.

Prior to her time at Pfizer Balice-Gordon was professor of neuroscience and chair of the neuroscience graduate group in the Perelman School of Medicine at the University of Pennsylvania, where she currently holds an adjunct appointment.

In her new role at Sanofi Balice-Gordon will based at the firm's Framingham, Massachusetts R&D site and lead research efforts associated with Sanofi's early portfolio in neurobiology, including neurodegeneration, neuroinflammation and central nervous system inherited diseases.

18th May 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics